Atlas Trials

CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study

Clinical trial NCT05206331 · RECRUITING

Trial details

NCT number
NCT05206331
Sponsor
Margarita Louise Zuley
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Breast Cancer
Start date
2022-02-01
Primary completion
2026-11-30
Enrollment
2100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.